Andrea Fava
@andreafava
Followers
545
Following
744
Media
24
Statuses
281
Rheumatologist and physician scientist @JohnsHopkins 🇮🇹🇺🇸| Studying mechanisms of #Lupus | Immunology | Computational biology
Baltimore, MD
Joined January 2010
RT @TheLancetRheum: NEW Correspondence—Preload deficiency as a treatable cause of fatigue and exercise intolerance in #SLE .
0
5
0
Preload deficiency as a treatable cause of fatigue and exercise intolerance in SLE - The Lancet Rheumatology
thelancet.com
Fatigue and exercise intolerance affect more than 90% of patients with systemic lupus erythematosus (SLE), often persisting despite inactive disease.1 The pathophysiology of the disease remains...
1
0
4
RT @luigiadamomdphd: @YooJinKimYJK led our @hopkinsheart + @andreafava @HopkinsRheum team in investigating recurrent pericarditis in Lupus.….
jamanetwork.com
This cohort study investigates the incidence of recurrent pericarditis among patients with a history of systemic lupus erythematosus (SLE) and factors associated with recurrence.
0
5
0
RT @RheumNow: 268/279 SLE pts w/ kidney biopsy for proteinuria were Dx w/ lupus nephritis. Proliferative LN (III/IV+V) had higher levels of….
0
7
0
RT @ACR_Journals: Levels of anti-C1q and anti-dsDNA were independently associated with proliferative lupus nephritis. In proliferative LN,….
0
20
0
RT @preprintclub: Tomorrow #preprintHub1 @nicolas_ruffin from @karolinskainst will present a #preprint by @luigiadamomdphd lab showing how….
biorxiv.org
Cardiovascular disease remains the leading cause of death worldwide. A primary driver of cardiovascular mortality is ischemic heart failure, a form of cardiac dysfunction that develops in patients...
0
13
0
RT @RheumNow: Low urinary IL16 levels at 12 months predicts kidney survival at 3 years better than proteinuria - @Andreafava @rheumnow #R….
0
3
0
Thanks to @FNIH_Org, @NIDDKgov , @NIH_NIAMS, @LupusOrg, @LupusResearch, the Jerome L Greene Foundation, and the Plank Foundation for their support to this work and its future development!.
0
0
3
🔬 Exciting news in #Lupus! Our latest study is out. Discover how urinary biomarkers can transform lupus nephritis diagnosis & guide treatment. Plus novel insights into disease mechanism 🚀🚀. Dive into the research here #Rheumatology #Nephrology.
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis: . @andreafava @HopkinsMedicine .#Nephrology.
4
16
54
RT @JCI_insight: Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis: https:/….
0
2
0
Wonderful presentation by @celia_ida on a possibly novel cell type implicated in lupus nephritis #ACR23 #ACRBest.
A#2427 #ACR23 @RheumNow .PR3+ cell abundance higher in prolif LN, more than membranous. Mostly in tuberulointerstitium.Density of PR3+ higher in glomueruli of prolif LN.Correlates with activity, not chronicity.Urinary PR3 predict renal fxn loss at 3y.@jhrheumatology @andreafava
0
2
9
RT @celia_ida: Honoured to receive this award! Huge thanks to @LupusAcademy for the opportunity and gratitude to my mentor @andreafava for….
0
1
0
RT @lupus_hub: CONGRESS #EULAR2023 | @andreafava presented data on urinary biomarker levels at 3 months predicting treatment response at 1….
0
8
0
RT @jhrheumatology: ‼️ Application Opening ‼️.Join us as a postdoc #T32 research fellow in the Division of #Rheumatology! Learn more: https….
0
6
0
RT @jhrheumatology: Kicking us off this morning: Many of our @HopkinsMedicine rheumatologists are presenting during the #ACR22 virtual and….
0
1
0
#Hiring Join our research @HopkinsRheum to discover new treatments and molecularly redefine kidney #lupus using many omics? Computational only or hybrid with wet lab experience. Fun guaranteed. Physician-scientists most welcome. T32. DM me! @LupusOrg @RheumResearch
0
1
12
IL-16 is linked to lupus nephritis activity: a novel biomarker and potential therapeutic target discovered by the Accelerating Medicines Partnership! @soumya_boston @Deepakarao @HopkinsMedNews @jhrheumatology @RheumNow @NIH_NIAMS @LupusOrg @LupusResearch.
acrjournals.onlinelibrary.wiley.com
Objective Current lupus nephritis (LN) treatments are effective in only 30% of patients, emphasizing the need for novel therapeutic strategies. We undertook this study to develop mechanistic hypoth...
3
18
50
RT @jhrheumatology: Follow some of our Johns Hopkins rheumatologists on Twitter:. @BritAdlerMD .@cappelliMD .@DrLisaCS .@JuliePaikMD .@Myma….
0
2
0
RT @MaxKonigMD: Hard to keep up with all the good news. Congrats to @philseo, Program Director extraordinaire and Director of the Johns H….
0
5
0